circRNA from APP Gene Changes in Alzheimer's Disease Human Brain

被引:7
|
作者
Urdanoz-Casado, Amaya [1 ]
Sanchez-Ruiz de Gordoa, Javier [1 ,2 ]
Robles, Maitane [1 ]
Roldan, Miren [1 ]
Macias Conde, Monica [1 ,2 ]
Acha, Blanca [1 ]
Blanco-Luquin, Idoia [1 ]
Mendioroz, Maite [1 ,2 ]
机构
[1] Univ Publ Navarra UPNA, Navarra Inst Hlth Res, Neuroepigenet Lab Navarrabiomed, Complejo Hosp Navarra IdiSNA, Pamplona 31008, Navarra, Spain
[2] Complejo Hosp Navarra, IdiSNA Navarra Inst Hlth Res, Dept Neurol, Pamplona 31008, Navarra, Spain
关键词
Alzheimer's disease; entorhinal cortex; circRNA; mRNA; Amyloid beta; APP; AMYLOID PRECURSOR PROTEIN; CIRCULAR RNAS; NEUROPATHOLOGIC ASSESSMENT; EXPRESSION; BACE1; SCLEROSIS; PROFILES; ABUNDANT; MIR-186; EUROPE;
D O I
10.3390/ijms24054308
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is the most common cause of age-related dementia. Amyloid precursor protein (APP) is the precursor of A beta peptides, and its role in AD has been widely investigated. Recently, it has been reported that a circular RNA (circRNA) originated from APP gene can serve as a template for A beta synthesis, postulating it as an alternative pathway for the A beta biogenesis. Moreover, circRNAs play important roles in brain development and in neurological diseases. Therefore, our aim was to study the expression of a circAPP (hsa_circ_0007556) and its linear cognate in AD human entorhinal cortex, a brain region most vulnerable to AD pathology. First, we confirmed the presence of circAPP (hsa_circ_0007556) in human entorhinal cortex samples using RT-PCR and Sanger sequencing of PCR products. Next, a 0.49-fold decrease in circAPP (hsa_circ_0007556) levels was observed in entorhinal cortex of AD cases compared to controls (p-value < 0.05) by qPCR. In contrast, APP mRNA expression did not show changes in the entorhinal cortex between AD cases and controls (Fold-change = 1.06; p-value = 0.81). A negative correlation was found between A beta deposits and circAPP (hsa_circ_0007556) and APP expression levels (Rho Spearman = -0.56, p-value < 0.001 and Rho Spearman = -0.44, p-values < 0.001, respectively). Finally, by using bioinformatics tools, 17 miRNAs were predicted to bind circAPP (hsa_circ_0007556), and the functional analysis predicted that they were involved in some pathways, such as the Wnt-signaling pathway (p = 3.32 x 10(-6)). Long-term potentiation (p = 2.86 x 10(-5)), among others, is known to be altered in AD. To sum up, we show that circAPP (hsa_circ_0007556) is deregulated in the entorhinal cortex of AD patients. These results add to the notion that circAPP (hsa_circ_0007556) could be playing a role in the pathogenesis of AD disease.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Golgi defects enhance APP amyloidogenic processing in Alzheimer's disease
    Joshi, Gunjan
    Wang, Yanzhuang
    BIOESSAYS, 2015, 37 (03) : 240 - 247
  • [32] Modelling Alzheimer's disease using human brain organoids: current progress and challenges
    Yanakiev, Mario
    Soper, Olivia
    Berg, Daniel A.
    Kang, Eunchai
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2022, 25
  • [33] Phenylalanine Metabolism Is Dysregulated in Human Hippocampus with Alzheimer's Disease Related Pathological Changes
    Liu, Pan
    Yang, Qian
    Yu, Ning
    Cao, Yan
    Wang, Xue
    Wang, Zhao
    Qiu, Wen-Ying
    Ma, Chao
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (02) : 609 - 622
  • [34] THE HUMAN BRAIN: THE PATH FROM NORMAL AGING TO ALZHEIMER'S DISEASE
    Bouras, Constantin
    NEUROBIOLOGY OF AGING, 2016, 39 : S11 - S11
  • [35] Two Routes to Alzheimer's Disease Based on Differential Structural Changes in Key Brain Regions
    Hollenbenders, Yasmin
    Pobiruchin, Monika
    Reichenbach, Alexandra
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (04) : 1399 - 1412
  • [36] Neural changes in Alzheimer's disease from circuit to molecule: Perspective of optogenetics
    Yang, Qinghu
    Song, Da
    Qing, Hong
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 79 : 110 - 118
  • [37] Transcriptional Regulation of The Alzheimer's Disease-related Gene, Nicastrin
    Yang Mei
    Cai Fang
    Pan Qian
    Long Zhi-Gao
    Xia Jia-Hui
    Xia Kun
    Zhang Zhuo-Hua
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2009, 36 (08) : 994 - 1002
  • [38] Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease
    Mann, David M. A.
    Davidson, Yvonne S.
    Robinson, Andrew C.
    Allen, Nancy
    Hashimoto, Tadafumi
    Richardson, Anna
    Jones, Matthew
    Snowden, Julie S.
    Pendleton, Neil
    Potier, Marie-Claude
    Laquerriere, Annie
    Prasher, Vee
    Iwatsubo, Takeshi
    Strydom, Andre
    ACTA NEUROPATHOLOGICA, 2018, 136 (04) : 569 - 587
  • [39] Longitudinal behavioral changes in the APP/PS1 transgenic Alzheimer's Disease model
    Ferguson, Sherry A.
    Sarkar, Sumit
    Schmued, Larry C.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 242 : 125 - 134
  • [40] Targeting Amyloidogenic Processing of APP in Alzheimer's Disease
    Zhao, Jing
    Liu, Xinyue
    Xia, Weiming
    Zhang, Yingkai
    Wang, Chunyu
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13